Covered recipient · General Payments record
AMY E GONZALEZ
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$566.72
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $211.42 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $81.70 | 5 |
| BIOTRONIK NRO, Inc. | $36.11 | 2 |
| PFIZER INC. | $22.36 | 1 |
| GlaxoSmithKline, LLC. | $21.90 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.22 | 1 |
| DEXCOM, INC. | $16.12 | 1 |
| Astellas Pharma US Inc | $15.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $15.01 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139366957 | CMS |
| BIOTRONIK NRO, Inc. | $16.16 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153856339 | CMS |
| BIOTRONIK NRO, Inc. | $19.95 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153856333 | CMS |
| Dexcom, Inc. | $16.12 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278983 | CMS |
| GlaxoSmithKline, LLC. | $21.90 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116572185 | CMS |
| Novo Nordisk Inc | $15.79 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097597435 | CMS |
| Novo Nordisk Inc | $16.79 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097031050 | CMS |
| Novo Nordisk Inc | $16.79 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096617040 | CMS |
| Novo Nordisk Inc | $16.07 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097393235 | CMS |
| Novo Nordisk Inc | $16.26 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096655636 | CMS |
| PFIZER INC. | $22.36 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131518361 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.22 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151066853 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.